Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
13F holders, Q1 2026 (March 31)2holders −3
1new positions
4sold out
$1.26avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Travere Therapeutics Inc. (tvtx 2.25 03/01/29) in their 13F filings, down 3 from Q4 2025. 1 opened new positions and 4 sold out. The largest holders were Janus Henderson Group PLC ($6.0M) and Northwestern Mutual Wealth Management Co. ($3K).
- Company
- Travere Therapeutics Inc. (tvtx 2.25 03/01/29)
- CUSIP
- 89422GAA5
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6.0M |
| Exits | 4 | $4.7M |
All 13F filers, Q4 2025 → Q1 2026: 4,779,000 shares bought and 3,337,000 shares sold, net +1,442,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Janus Henderson Group PLC | 0.00% | New | 4,779,000 | $6.0M |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 2,000 | $3K |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 2.25 03/01/29)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 2.25 03/01/29) the manager owns.